Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 November 2023, 10:00 (CET) to 23 November 2023, 12:00 (CET)

Submitted by Anonymous (not verified) on 21 December 2023 - 13:00

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 November 2023, 10:00 (CET) to 23 November 2023, 12:00 (CET)

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 29 January 2024 to 2 February 2024

Submitted by Anonymous (not verified) on 21 December 2023 - 12:55

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 29 January 2024 to 2 February 2024

18th industry stakeholder platform - operation of European Union (EU) pharmacovigilance, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 November 2023, 13:00 (CET) to 22 November 2023, 16:30 (CET)

Submitted by Anonymous (not verified) on 21 December 2023 - 12:00

18th industry stakeholder platform - operation of European Union (EU) pharmacovigilance, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 November 2023, 13:00 (CET) to 22 November 2023, 16:30 (CET)

Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system, Online, from 26 February 2024 to 28 February 2024

Submitted by Anonymous (not verified) on 21 December 2023 - 10:39

Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system, Online, from 26 February 2024 to 28 February 2024

Human medicines European public assessment report (EPAR): Defitelio, defibrotide, Date of authorisation: 18/10/2013, Revision: 16, Status: Authorised

Submitted by Anonymous (not verified) on 20 December 2023 - 16:34

Human medicines European public assessment report (EPAR): Defitelio, defibrotide, Date of authorisation: 18/10/2013, Revision: 16, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness